Explore emerging insights from the 2014 Ebola outbreak in West Africa through this informative conference talk from the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Hosted by Michael Schmidt, Professor and Vice Chairman of Microbiology and Immunology at the Medical University of South Carolina, the presentation features expert speakers from the Centers for Disease Control and Prevention, National Microbiology Lab, and Emory University School of Medicine. Gain valuable knowledge about the CDC's involvement and response to the outbreak, ongoing vaccine development efforts, and the risk-benefit analysis of potential treatments. Delve into discussions on health safety conditions, clinical trials, and the challenges faced by healthcare professionals in affected regions. Learn about the latest advancements in Ebola research and public health strategies in this comprehensive 41-minute talk organized by the American Society for Microbiology.
Overview
Syllabus
Introduction
CDCs Involvement in the Outbreak
CDCs Response
Questions
Dr Thompson
Simon Bennett
Melanie Gantz
Koh Pinger
Will you go to DRC
Health safety conditions have changed
Vaccine in animal testing
Vaccines in clinical trials
Riskbenefit ratio
Conclusion
Dr Mehta
Dr Owusu
Dr Burger
Mr Mehta
Dr Bennett
Chemical shop
Taught by
American Society for Microbiology
